Biodistribution and dosimetry of [11C]FLB457 in human

Biodistribution and dosimetry of [11C]FLB457 in human - Biodistribution and dosimetry of [11C]FLB457 in human

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006797

Enrollment

Registered

2011-12-01

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Intravenous injection of [11C]FLB457 (6mCi)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy male volunteers (20 years or older) who do not have any psychiatric disorders or serious medical illnesses and who are able to understand an explanatory document and give consent are included in this study

Exclusion criteria

Exclusion criteria: -Under treatment of physical illness -Having abnormal findings in physical examination and blood and urine tests -Within 6 months after the last injection of radioisotopes

Design outcomes

Primary

Measure	Time frame
Effective dose after injecting [11C]FLB457 in healthy humans	—

Secondary

Measure	Time frame
Biodistribution and radiation absorbed dose of each organs and the excretion pathway after injecting [11C]FLB457	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026